Unmet rehabilitation needs in cancer survivors: A population-level analysis.

S Subha Hanif (Mayo Clinic Rochester, Rochester, MN) T Toure Barksdale (Department of Physical Medicine and Rehabilitation, Mayo Clinic Rochester, Rochester, MN) A Andrea L. Cheville (Department of Physical Medicine and Rehabilitation, Mayo Clinic Rochester, Rochester, MN) J Jeph Herrin (Yale School of Medicine, New Haven, CT) K Kathryn Jean Ruddy (Department of Oncology, Mayo Clinic Rochester, Rochester, MN) D Deirdre R. Pachman (Division of Community Internal Medicine, Geriatrics, and Palliative Care, Mayo Clinic Rochester, Rochester, MN) V Veronica Grzegorczyk (Department of Physical Medicine and Rehabilitation Research, Mayo Clinic Rochester, Rochester, MN)

Abstract

1584 Background: Decades of evidence demonstrate that patients across the cancer continuum may benefit from validated rehabilitation services, yet delivery remains inconsistent. Prior reports of underuse have largely relied on small, single-site cohorts and have lacked population-level estimates of service need, referral, and visit completion, contributing to the assumption that provider reluctance to refer is a primary driver. Using post hoc exploratory analyses of population-level trial data, we evaluated patient- and system-level factors associated with non-use of rehabilitation services. Methods: This secondary analysis used data from the Enhanced Electronic Health Record–Facilitated Cancer Symptom Control (E2C2) pragmatic trial, an unblinded, stepped-wedge, cluster-randomized cohort study comparing an EHR-embedded symptom surveillance and management system with usual care. All patients receiving care in Mayo Clinic Midwest medical oncology practices were enrolled regardless of cancer stage or phase. Symptoms and physical function were assessed using 11-point numerical rating scales linked to oncology encounters. Sociodemographic and clinical characteristics and all outpatient rehabilitation encounters across the Mayo Clinic Enterprise were extracted from the EHR. Rates and types of completed, canceled, and no-show rehabilitation encounters were examined. Results: Between March 28, 2019, and January 31, 2023, 50,207 patients were enrolled; 34% reported moderate or severe physical function impairment during follow-up. Despite this, only 8,818 patients (17.6%) completed at least one rehabilitation encounter. Of 91,220 encounters scheduled, 57,669 (63.3%) were completed (mean 6.5; median 3 per participant), leaving a substantial proportion canceled or no-showed (n=33,523, 36.7%). Completed encounters were predominantly physical therapy (68.3%), with fewer occupational therapy (16.4%), physician (9.4%), and speech therapy (4.2%) visits. Encounters were concentrated among patients with breast, hematologic, gastrointestinal, and genitourinary cancers. Completion was more likely among patients who were older, female, partnered, retired, and federally insured, whereas cancellations and no-shows were more common among younger, racial or ethnic minority, urban, unpartnered, employed, college-educated, and commercially insured patients (all P <0.001). Virtual visits and encounters in community (vs academic) settings were more likely to be completed (all P <0.001). Conclusions: A substantial gap persists between cancer survivors’ rehabilitation needs and service receipt, varying by cancer type and sociodemographic factors. High cancellation and no-show rates suggest that underuse extends beyond referral and underscore the need for redesigned, more accessible rehabilitation delivery models.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
Pages 1584-1584
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (7)

S

Subha Hanif

Mayo Clinic Rochester, Rochester, MN

T

Toure Barksdale

Department of Physical Medicine and Rehabilitation, Mayo Clinic Rochester, Rochester, MN

A

Andrea L. Cheville

Department of Physical Medicine and Rehabilitation, Mayo Clinic Rochester, Rochester, MN

J

Jeph Herrin

Yale School of Medicine, New Haven, CT

K

Kathryn Jean Ruddy

Department of Oncology, Mayo Clinic Rochester, Rochester, MN

D

Deirdre R. Pachman

Division of Community Internal Medicine, Geriatrics, and Palliative Care, Mayo Clinic Rochester, Rochester, MN

V

Veronica Grzegorczyk

Department of Physical Medicine and Rehabilitation Research, Mayo Clinic Rochester, Rochester, MN